Viral oncogene-induced DNA damage response is activated in Kaposi sarcoma tumorigenesis.
Kaposi sarcoma is a tumor consisting of Kaposi sarcoma herpesvirus (KSHV)-infected tumor cells that express endothelial cell (EC) markers and viral genes like v-cyclin, vFLIP, and LANA. Despite a strong link between KSHV infection and certain neoplasms, de novo virus infection of human primary cells...
Guardado en:
Autores principales: | Sonja Koopal, Johanna H Furuhjelm, Annika Järviluoma, Sari Jäämaa, Pawan Pyakurel, Christel Pussinen, Maria Wirzenius, Peter Biberfeld, Kari Alitalo, Marikki Laiho, Päivi M Ojala |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2007
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2f23eda7c9764a07baabb81a431641b6 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Nucleophosmin phosphorylation by v-cyclin-CDK6 controls KSHV latency.
por: Grzegorz Sarek, et al.
Publicado: (2010) -
Epidemiology of Kaposi’s Sarcoma
por: Sophie Grabar, et al.
Publicado: (2021) -
Disseminated Kaposi Sarcoma
por: Laura E. Goyack, et al.
Publicado: (2021) -
Exploitation of the complement system by oncogenic Kaposi's sarcoma-associated herpesvirus for cell survival and persistent infection.
por: Myung-Shin Lee, et al.
Publicado: (2014) -
Kaposi's sarcoma herpesvirus microRNAs target caspase 3 and regulate apoptosis.
por: Guillaume Suffert, et al.
Publicado: (2011)